Recall archive / FDA drug enforcement

Preferred Pharmaceuticals, Inc. The Physician's Solution., Lansoprazole Delayed-Release Capsules, 15mg, Generic for P... — FDA record D-0769-2022

Reported terminated

Status as reported in the agency record. FDA warns that enforcement status may not track the current recall lifecycle; check the current official notice.

Source date Mar 28, 2022. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.

Archive changed Oct 1, 2026. USDA FSIS records are unavailable; check FSIS directly. Source coverage and dates.

What the record says

Product: Preferred Pharmaceuticals, Inc. The Physician's Solution., Lansoprazole Delayed-Release Capsules, 15mg, Generic for Prevacid, 90-Count Bottle, Manufacturer: Dr Reddy's Laboratories Limited, NDC 68788-6390-09
Reason: Out of specification results observed in dissolution during long term stability testing.
Classification: Class II
Recalling firm: Preferred Pharmaceuticals, Inc.
Quantity: 791 bottles of 90 - Count
Agency-reported status: Terminated
Source record identifier: D-0769-2022

Open the official record

What the recall classes mean. Classification is an agency assessment, not individual medical advice.

Lot and product identifiers

Label field	Details supplied by the agency
Lot, code or applicability	Lots: H0221R, D3021T, D2221J, D1321X, Exp.12/31/2023.

Match all identifying details in the current notice. A brand name alone is not enough.

Distribution

Nationwide in the USA and CA.

States below are derived from the distribution text, including nationwide wording. They are not inferred from the firm's address.

Dates in the source

Report date: Apr 20, 2022
Recall initiation date: Mar 28, 2022
Center classification date: Apr 14, 2022
Termination date: May 10, 2022

FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.